SCIMITAR (Closed to Recruitment)
Smoking is an important health issue, especially amongst people with severe mental health issues such as schizophrenia or bipolar disorder.
This study is looking to evaluate a ‘bespoke smoking cessation’ (BSC) service specifically tailored to individual patients with severe mental illness. Participants will either receive care as normal or the BSC. Participants recruited to the study will be followed up for 12 months. After 6 and 12 months they will be requested to complete questionnaires on their smoking status, general and mental health and their satisfaction with specified aspects of the BSC. They will also have their smoking status verified by measuring the amount of carbon monoxide (CO) in their breath.
This study has now closed to recruitment.
Findings so far:
It was found that the odds of quitting at 12 months was higher in the bespoke smoking cessation than the group of people who were randomised to usual GP care.
Please click here if you wish to go to the study website.
The study further found that a bespoke smoking cessation package designed for people with severe mental illness is more effective than the usual care option. The full paper is available free from the Addiction journal.